Loading...

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada

BACKGROUND: For Canadian men, prostate cancer (PCa) is the most common cancer and the 3rd leading cause of cancer mortality. Men dying of PCa do so after failing castration. The management of metastatic castration-resistant prostate cancer (mCRPC) is complex and the associated drug treatments are in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Dragomir, Alice, Dinea, Daniela, Vanhuyse, Marie, Cury, Fabio L, Aprikian, Armen G
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099156/
https://ncbi.nlm.nih.gov/pubmed/24927758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-14-252
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!